Replies to post #35666 on RespireRx Pharmaceuticals Inc (fka RSPI)

[haysaw]

There will likely be a better life for Ampakines if Corx ceases to exist (or current mgmt concedes). The molecules don't go the way of shareholders and mgmnt should the company fail or put themselves up for sale--this is what I mean by a little hope may be more dangerous/risky (as an investor). It is essential to look at the bigger picture when evaluating the prospects of Ampakines.

[davidal66]

What is next is simple. They raise money, or they do not, are unable to do so. To give some credit to their integrity, I don't believe they wish to go from paycheck to paycheck, letting the ampakines go undeveloped. I believe they will sell the company if they cannot move the compounds forward. I also believe there is some sort of timing here as well. Their plan a. is to raise money, repurchase RD rights/IV compounds, and do another deal. Plan b. is to sell the company if a. doesn't occur.

Is Servier interested in any of these machinations? Are their other high impact suitors? Maybe Cortex is unwilling to examine the myriad of other possible deals/partnerships as this would put the cabash on Cortex' share price.